We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Kroger
KR
$36.3B
| $628K | ﹤0.01% |
+14,079
| New | +$647K |
|
752
Adicet Bio
ACET
$76.7M
| $620K | ﹤0.01% |
+4,336
| New | +$1.08M |
|
753
Adaptive Biotechnologies
ADPT
$3.6B
| $618K | ﹤0.01% |
80,863
-34,963
| -30% | -$272K |
|
754
Regenxbio
RGNX
$615M
| $615K | ﹤0.01% |
27,123
+16,531
| +156% | +$374K |
|
755
KeyCorp
KEY
$24.3B
| $612K | ﹤0.01% |
35,131
-75,924
| -68% | -$1.34M |
|
756
AZZ Inc
AZZ
$4.41B
| $605K | ﹤0.01% |
+15,059
| New | +$592K |
|
|
TIG
757
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $604K | ﹤0.01% |
100,639
-93,529
| -48% | -$325K |
|
758
JELD-WEN Holding
JELD
$98.2M
| $604K | ﹤0.01% |
62,549
-40,231
| -39% | -$390K |
|
759
Upland Software
UPLD
$14.4M
| $600K | ﹤0.01% |
8,418
-53,414
| -86% | -$3.98M |
|
760
Praxis Precision Medicines
PRAX
$8.25B
| $600K | ﹤0.01% |
16,801
-1,002
| -6% | -$31.2K |
|
761
Citizens Financial Group
CFG
$30.8B
| $597K | ﹤0.01% |
15,152
| – | – |
|
762
BlueLinx
BXC
$465M
| $595K | ﹤0.01% |
8,361
-334
| -4% | -$22.8K |
|
763
Stanley Black & Decker
SWK
$14.6B
| $594K | ﹤0.01% |
7,912
| – | – |
|
|
DZSI
764
DELISTED
DZS Inc. Common Stock
DZSI
| $593K | ﹤0.01% |
46,790
-41,232
| -47% | -$524K |
|
765
Pixelworks
PXLW
$37.2M
| $592K | ﹤0.01% |
+27,888
| New | +$499K |
|
766
DLH Holdings
DLHC
$75.7M
| $591K | ﹤0.01% |
49,792
| – | – |
|
|
GNTY
767
DELISTED
Guaranty Bancshares
GNTY
| $591K | ﹤0.01% |
17,047
-552
| -3% | -$19.6K |
|
|
ASTR
768
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $584K | ﹤0.01% |
89,690
+78,424
| +696% | +$616K |
|
769
EverCommerce
EVCM
$2.12B
| $581K | ﹤0.01% |
78,151
-18,742
| -19% | -$143K |
|
770
Sterling Infrastructure
STRL
$16.5B
| $581K | ﹤0.01% |
17,712
+6,024
| +52% | +$177K |
|
771
Flexsteel Industries
FLXS
$317M
| $580K | ﹤0.01% |
37,642
-20,717
| -35% | -$311K |
|
772
Evolution Petroleum
EPM
$131M
| $574K | ﹤0.01% |
76,000
-1,301
| -2% | -$9.78K |
|
773
RingCentral
RNG
$4.77B
| $573K | ﹤0.01% |
16,182
-4,356
| -21% | -$156K |
|
774
Barnes & Noble Education
BNED
$451M
| $568K | ﹤0.01% |
+3,246
| New | +$774K |
|
775
Nature's Sunshine
NATR
$365M
| $563K | ﹤0.01% |
67,625
-2,140
| -3% | -$18.1K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.